Thomas Lenarz

The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients

M. K. Steuer-Vogt, V. Bonkowsky, Petra Ambrosch et al. · European Journal of Cancer · 2001 · 169 citations

Medicine, Neck Surgery, Oncology +7

Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II

Andreas Dietz, Gunnar Wichmann, Thomas Kuhnt et al. · Annals of Oncology · 2018 · 83 citations · Full text

Medicine, Oncology, Surgery +17

Induction chemotherapy (IC) docetaxel (T), cisplatin (P), 5-fluorouracil (F) (TPF), or TP followed by concomitant boost radiotherapy (R) with or without cetuximab (E) for functional organ preservation (FOP) of resectable laryngeal and hypopharyngeal cancer (LHSCC): First results of the phase II randomized DeLOS-II study.

Andreas Dietz, Michael Flentje, Rudolf Hagen et al. · Journal of Clinical Oncology · 2014 · 12 citations

Medicine, Oncology, Surgery +15

Final results of the randomized phase II DeLOS-II trial: Induction chemotherapy (IC) followed by radiotherapy (R) vs. cetuximab (E) plus IC and R for functional larynx preservation in resectable laryngeal and hypopharyngeal cancer (LHSCC).

Andreas Dietz, Gunnar Wichmann, Michael Flentje et al. · Journal of Clinical Oncology · 2016 · 11 citations

Medicine, Otolaryngology, Surgery +17